| Amanda Testa, PHARMD | |
|
4 Jenkins Rd, Bedford, NH 03110-5038 | |
| (603) 472-2501 | |
| Not Available |
| Full Name | Amanda Testa |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 4 Jenkins Rd, Bedford, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538761085 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 3658 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amanda Testa, PHARMD 7 Sterling Dr, Londonderry, NH 03053-2339 Ph: (603) 315-4794 | Amanda Testa, PHARMD 4 Jenkins Rd, Bedford, NH 03110-5038 Ph: (603) 472-2501 |
News Archive
New research in mice has found that a father's stress affects the brain development of his offspring. This stress changes the father's sperm, which can then alter the brain development of the child. This new research provides a much better understanding of the key role that fathers play in the brain development of offspring.
Health care–associated infections (HAIs) account for a large proportion of the harms caused by health care and are associated with high costs. ... [Using a simulation, the researchers found that the] total annual costs for the 5 major infections were $9.8 billion (95% CI, $8.3-$11.5 billion), with surgical site infections contributing the most to overall costs (33.7% of the total), followed by ventilator-associated pneumonia (31.6%), central line–associated bloodstream infections (18.9%), C difficile infections (15.4%), and catheter-associated urinary tract infections (<1%). ... recent analyses indicate that at least 50% are preventable. ...
The third edition of the Ontario Cancer Plan (OCP) ensures our cancer system serves the changing and growing needs of Ontarians. The Cancer Plan outlines priorities for cancer services, sets a course to transform cancer services from the patient perspective, and is driven by a commitment to quality across the cancer journey - from prevention to survivorship or palliative care - as the most effective way to manage cancer.
SMT Research and Development Ltd. of Herzliya Pituach, Israel announced today a significant investment by OrbiMed Advisors LLC. SMT is finalizing the development of a novel embolic protection device designed for use during Transcatheter Aortic Valve Implantation procedures.
› Verified 3 days ago
Dr. Falon Anne Kaspszak, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 209 Route 101, Bedford, NH 03110 Phone: 603-472-3919 Fax: 603-472-7448 | |
Kim Ahearn, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 209 Route 101, Bedford, NH 03110 Phone: 603-472-3919 Fax: 603-472-7448 | |
Laurie Keith, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 258 Wallace Rd, Bedford, NH 03110 Phone: 603-472-5847 | |
Nicholas Driscoll, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 258 Wallace Rd, Bedford, NH 03110 Phone: 603-472-5847 | |
Mrs. Ronda Lee Hatin, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5 Colby Ct, Bedford, NH 03110 Phone: 603-622-2320 | |
Mrs. Lori Ellen Connors, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 220 S River Rd, Bedford, NH 03110 Phone: 603-263-0062 | |
Ms. Narmin Pirmohamed, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8 Technology Dr, Bedford, NH 03110 Phone: 603-626-6200 |